135 related articles for article (PubMed ID: 38676797)
1. Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.
Upton DH; Ziegler DS; Tsoli M
Methods Mol Biol; 2024; 2806():75-90. PubMed ID: 38676797
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
3. Patient-Derived Orthotopic Xenograft Models for High-Grade Pediatric Brain Cancers.
Buck J; Hii H; Endersby R
Methods Mol Biol; 2024; 2806():41-53. PubMed ID: 38676795
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
Xu Z; Kader M; Sen R; Placantonakis DG
Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
[TBL] [Abstract][Full Text] [Related]
5. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.
Wang W; Cho HY; Rosenstein-Sisson R; Marín Ramos NI; Price R; Hurth K; Schönthal AH; Hofman FM; Chen TC
J Neurosurg; 2018 Mar; 128(3):695-700. PubMed ID: 28409734
[TBL] [Abstract][Full Text] [Related]
7. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
[TBL] [Abstract][Full Text] [Related]
8. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression.
Candolfi M; Curtin JF; Nichols WS; Muhammad AG; King GD; Pluhar GE; McNiel EA; Ohlfest JR; Freese AB; Moore PF; Lerner J; Lowenstein PR; Castro MG
J Neurooncol; 2007 Nov; 85(2):133-48. PubMed ID: 17874037
[TBL] [Abstract][Full Text] [Related]
9. Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish.
Ai X; Ye Z; Xiao C; Zhong J; Lancman JJ; Chen X; Pan X; Yang Y; Zhou L; Wang X; Shi H; Zhang D; Yao Y; Cao D; Zhao C
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35199829
[TBL] [Abstract][Full Text] [Related]
10. An orthotopic glioblastoma animal model suitable for high-throughput screenings.
Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281
[TBL] [Abstract][Full Text] [Related]
11. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.
Shu Q; Wong KK; Su JM; Adesina AM; Yu LT; Tsang YT; Antalffy BC; Baxter P; Perlaky L; Yang J; Dauser RC; Chintagumpala M; Blaney SM; Lau CC; Li XN
Stem Cells; 2008 Jun; 26(6):1414-24. PubMed ID: 18403755
[TBL] [Abstract][Full Text] [Related]
12. Orthotopic brain tumor models derived from glioblastoma stem-like cells.
Eyme KM; Sammarco A; Badr CE
Methods Cell Biol; 2022; 170():1-19. PubMed ID: 35811093
[TBL] [Abstract][Full Text] [Related]
13. Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.
Kerstetter-Fogle AE; Harris PLR; Brady-Kalnay SM; Sloan AE
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698368
[TBL] [Abstract][Full Text] [Related]
14. Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts.
Koessinger AL; Koessinger D; Stevenson K; Cloix C; Mitchell L; Nixon C; Gomez-Roman N; Chalmers AJ; Norman JC; Tait SWG
Sci Rep; 2020 Sep; 10(1):15361. PubMed ID: 32958777
[TBL] [Abstract][Full Text] [Related]
15. Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis.
Morimoto T; Nakazawa T; Matsuda R; Maeoka R; Nishimura F; Nakamura M; Yamada S; Park YS; Tsujimura T; Nakagawa I
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397112
[TBL] [Abstract][Full Text] [Related]
16. Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas.
Wei X; Meel MH; Breur M; Bugiani M; Hulleman E; Phoenix TN
Acta Neuropathol Commun; 2021 Aug; 9(1):142. PubMed ID: 34425907
[TBL] [Abstract][Full Text] [Related]
17. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.
Joo KM; Kim J; Jin J; Kim M; Seol HJ; Muradov J; Yang H; Choi YL; Park WY; Kong DS; Lee JI; Ko YH; Woo HG; Lee J; Kim S; Nam DH
Cell Rep; 2013 Jan; 3(1):260-73. PubMed ID: 23333277
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP
Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951
[TBL] [Abstract][Full Text] [Related]
19. Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery.
Carlson BL; Pokorny JL; Schroeder MA; Sarkaria JN
Curr Protoc Pharmacol; 2011 Mar; Chapter 14(14):Unit 14.16. PubMed ID: 21743824
[TBL] [Abstract][Full Text] [Related]
20. Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
Hashizume R; Gupta N; Berger MS; Banerjee A; Prados MD; Ayers-Ringler J; James CD; VandenBerg SR
Neuro Oncol; 2010 Apr; 12(4):366-76. PubMed ID: 20308314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
